Recent Updates
Recently added Catalysts
AKBA Positive Sentiment Score: 75/100

Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference

Tuesday, July 8, 2025 1 min read
Key Takeaway: Akebia Therapeutics, a biopharmaceutical company focused on kidney disease, announced that its Chief Commercial Officer, Nik Grund, will participate in a Fireside Chat at the H.C. Wainwright 4th Annual Kidney Virtual Conference. The event is scheduled for July 14, 2025, at 10:00 AM EDT. A webcast of the presentation will be available on Akebia's website, offering insights into the company's developments in addressing kidney disease.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent industry conference highlights Akebia's commitment to kidney disease.
  • The presentation offers an opportunity for Akebia to showcase its insights and advancements.
  • Engagement with investors through a webcast enhances visibility and transparency.

Full Press Release Details

CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Nik Grund, Chief Commercial Officer, will participate in a Fireside Chat at the H.C. Wainwright 4th Annual Kidney Virtual Conference on Monday, July 14 at 10:00 AM EDT.
A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conference.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
mcarrasco@akebia.com

Frequently Asked Questions

When will Akebia's Fireside Chat occur?

The Fireside Chat is scheduled for July 14 at 10:00 AM EDT.

Who is participating in the Fireside Chat?

Nik Grund, Chief Commercial Officer of Akebia, will participate.

Where can I watch the webcast of the event?

The webcast will be available in the Investors section of Akebia's website.

What is the focus of Akebia Therapeutics?

Akebia focuses on improving the lives of those affected by kidney disease.

When was Akebia Therapeutics founded?

Akebia Therapeutics was founded in 2007.

Tags: AKBA Viatris Investor Conferences Healthcare Akebia Therapeutics kidney disease virtual conference HC Wainwright Nasdaq AKBA
Last updated: Jul 8, 2025